• Aurix can be used to treat wounds of any size, and any shape, including tunneling and undermining.
• Aurix has a 96.5% positive response rate in all types of chronic wounds. (deLeon 2011)
• Aurix begins acting immediately, and results are often seen after the first treatment.
• Aurix Centrifuge spin time is only 1 minute, and the gel is ready to apply in 5-8 minutes*. (*after blood draw)
• Aurix treatments fit well with natural clinic flows and timeline for typical patient clinical visits.
• Aurix can be used on patients actively taking blood thinning medication without delay in prep time.
• Aurix treatments provide autologous “Activated Platelets” and growth factors which are applied directly onto the wound bed.

Resolve Matrix™ is a thin, flexible, yet strong acellular wound dressing designed to support the body’s repair process during wound healing. It is derived from porcine peritoneum membrane and processed using the Optrix™ tissue cleansing methodology, which is optimized to remove antigens while preserving desirable tissue scaffold properties and components, including growth factors. Both its source material and unique cleansing process, provide a combination of highly desirable attributes that are appreciated during its clinical application and supporting role in the healing of wounds.

Restorigin amniotic membranes are procured through voluntary donation from scheduled cesarean procedures of full-term, live births. The natural properties of amniotic tissue provide mechanical protection and growth factors to aid in the management of diabetic foot ulcers and venous leg ulcers. Restorigin is a dual layer amnion that offers the flexibility of placing either side toward the wound, adheres naturally to the patient’s tissue without sutures or other fixation, and is stored at room temperature with a 5-year shelf-life.

HCPCS: Q4191